128 related articles for article (PubMed ID: 28668855)
1. Slow-release L-Cysteine (Acetium®) Lozenge Is an Effective New Method in Smoking Cessation. A Randomized, Double-blind, Placebo-controlled Intervention.
Syrjänen K; Eronen K; Hendolin P; Paloheimo L; Eklund C; Bäckström A; Suovaniemi O
Anticancer Res; 2017 Jul; 37(7):3639-3648. PubMed ID: 28668855
[TBL] [Abstract][Full Text] [Related]
2. Elimination of Cigarette Smoke-derived Acetaldehyde in Saliva by Slow-release L-Cysteine Lozenge Is a Potential New Method to Assist Smoking Cessation. A Randomised, Double-blind, Placebo-controlled Intervention.
Syrjänen K; Salminen J; Aresvuo U; Hendolin P; Paloheimo L; Eklund C; Salaspuro M; Suovaniemi O
Anticancer Res; 2016 May; 36(5):2297-306. PubMed ID: 27127136
[TBL] [Abstract][Full Text] [Related]
3. Effect of nicotine lozenges on affective smoking withdrawal symptoms: secondary analysis of a randomized, double-blind, placebo-controlled clinical trial.
Shiffman S
Clin Ther; 2008 Aug; 30(8):1461-75. PubMed ID: 18803988
[TBL] [Abstract][Full Text] [Related]
4. A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation.
Xiao D; Kotler M; Kang J; Wang C
J Addict Med; 2020; 14(1):69-77. PubMed ID: 31658113
[TBL] [Abstract][Full Text] [Related]
5. Awareness and Acceptance of Nicotine-free Smoking Intervention Methods (Acetium
Syrjänen K; Patrakka I; Paloniemi E; Soppi A; Hendolin P; Suovaniemi O
Anticancer Res; 2023 Nov; 43(11):4961-4968. PubMed ID: 37909990
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction.
Moolchan ET; Robinson ML; Ernst M; Cadet JL; Pickworth WB; Heishman SJ; Schroeder JR
Pediatrics; 2005 Apr; 115(4):e407-14. PubMed ID: 15805342
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of a nicotine lozenge for smoking cessation.
Shiffman S; Dresler CM; Hajek P; Gilburt SJ; Targett DA; Strahs KR
Arch Intern Med; 2002 Jun; 162(11):1267-76. PubMed ID: 12038945
[TBL] [Abstract][Full Text] [Related]
8. Electronic cigarettes for smoking cessation and reduction.
McRobbie H; Bullen C; Hartmann-Boyce J; Hajek P
Cochrane Database Syst Rev; 2014; (12):CD010216. PubMed ID: 25515689
[TBL] [Abstract][Full Text] [Related]
9. Interventions to reduce harm from continued tobacco use.
Lindson-Hawley N; Hartmann-Boyce J; Fanshawe TR; Begh R; Farley A; Lancaster T
Cochrane Database Syst Rev; 2016 Oct; 10(10):CD005231. PubMed ID: 27734465
[TBL] [Abstract][Full Text] [Related]
10. Novel Mineral-Vitamin Treatment for Reduction in Cigarette Smoking: A Fully Blinded Randomized Placebo-Controlled Trial.
Reihana PK; Blampied NM; Rucklidge JJ
Nicotine Tob Res; 2019 Oct; 21(11):1496-1505. PubMed ID: 31665746
[TBL] [Abstract][Full Text] [Related]
11. Smoking cessation in smokers who smoke menthol and non-menthol cigarettes.
Smith SS; Fiore MC; Baker TB
Addiction; 2014 Dec; 109(12):2107-17. PubMed ID: 24938369
[TBL] [Abstract][Full Text] [Related]
12. Subjective effects of the nicotine lozenge: assessment of abuse liability.
Houtsmuller EJ; Henningfield JE; Stitzer ML
Psychopharmacology (Berl); 2003 Apr; 167(1):20-7. PubMed ID: 12616334
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of bupropion and predictors of successful outcome in a sample of French smokers: a randomized placebo-controlled trial.
Aubin HJ; Lebargy F; Berlin I; Bidaut-Mazel C; Chemali-Hudry J; Lagrue G
Addiction; 2004 Sep; 99(9):1206-18. PubMed ID: 15317642
[TBL] [Abstract][Full Text] [Related]
14. Randomized Trial to Compare Smoking Cessation Rates of Snus, With and Without Smokeless Tobacco Health-Related Information, and a Nicotine Lozenge.
Nelson PR; Chen P; Battista DR; Pillitteri JL; Shiffman S
Nicotine Tob Res; 2019 Jan; 21(1):88-94. PubMed ID: 29373698
[TBL] [Abstract][Full Text] [Related]
15. Paths to tobacco abstinence: A repeated-measures latent class analysis.
McCarthy DE; Ebssa L; Witkiewitz K; Shiffman S
J Consult Clin Psychol; 2015 Aug; 83(4):696-708. PubMed ID: 25867447
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell).
Dautzenberg B; Nides M; Kienzler JL; Callens A
BMC Clin Pharmacol; 2007 Oct; 7():11. PubMed ID: 17922899
[TBL] [Abstract][Full Text] [Related]
17. The Fagerström Test for Nicotine Dependence as a predictor of smoking abstinence: a pooled analysis of varenicline clinical trial data.
Fagerström K; Russ C; Yu CR; Yunis C; Foulds J
Nicotine Tob Res; 2012 Dec; 14(12):1467-73. PubMed ID: 22467778
[TBL] [Abstract][Full Text] [Related]
18. Nicotine patch vs. nicotine lozenge for smoking cessation: an effectiveness trial coordinated by the Community Clinical Oncology Program.
Schnoll RA; Martinez E; Tatum KL; Glass M; Bernath A; Ferris D; Reynolds P
Drug Alcohol Depend; 2010 Mar; 107(2-3):237-43. PubMed ID: 20004065
[TBL] [Abstract][Full Text] [Related]
19. A review of the efficacy of smoking-cessation pharmacotherapies in nonwhite populations.
Robles GI; Singh-Franco D; Ghin HL
Clin Ther; 2008 May; 30(5):800-12. PubMed ID: 18555928
[TBL] [Abstract][Full Text] [Related]
20. A Randomized Trial Comparing the Effect of Nicotine Versus Placebo Electronic Cigarettes on Smoking Reduction Among Young Adult Smokers.
Tseng TY; Ostroff JS; Campo A; Gerard M; Kirchner T; Rotrosen J; Shelley D
Nicotine Tob Res; 2016 Oct; 18(10):1937-1943. PubMed ID: 26783292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
